You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. 3D Printed Ablative Re-Entry Vehicle Heat Shields

    SBC: MANTIS COMPOSITES INC            Topic: DLA23A003

    Re-Entry Vehicles (RVs) are a critical component of the strategic weapon arsenal. While physics packages themselves have a substantial deterrence value, the ability to deliver those weapons quickly and with high survivability unlocks the ability to maintain a truly global deterrence. However, these thermal protection systems are encountering two developing challenges: Industrial Base Attrition: Th ...

    STTR Phase I 2023 Department of DefenseDefense Logistics Agency
  2. Cost Effective TPS Technology for Hypersonic Applications

    SBC: RUSSELL TECHNICAL CONSULTING SERVICES LLC            Topic: DLA23A003

    The focus of this proposed Phase I STTR will be on identifying and assessing initial low-cost acreage TPS technologies applicable to hypersonic conventional and strategic system performance objectives addressing affordability, capacity, and supply chain resilience.  The initial feasibility assessment will utilize a low-cost TPS technology, carbon phenolic, and assess performance over a range of n ...

    STTR Phase I 2023 Department of DefenseDefense Logistics Agency
  3. Improved surface interface of OPF and PAN carbon fibers for Carbon-Carbon processing

    SBC: ALKEMIX CORPORATION            Topic: DLA23A003

    Specialized materials such as Carbon-Carbon (C-C) are required as primary structural and thermal protection elements to sustain the severe temperatures on the surface of Hypersonic Vehicles during high-speed flight. The C-C material currently qualified at Northrop in Hypersonic Glide-Bodies or “Aeroshells” consist of phenolic resin and a low fired, stretch broken polyacrylonitrile fiber (LFSP ...

    STTR Phase I 2023 Department of DefenseDefense Logistics Agency
  4. Low Cost MLMI as a Hypersonic Aerostructure with TPS

    SBC: Peregrine Falcon Corporation            Topic: DLA23A003

    As Hypersonic weapons enter the US arsenal there is a need for cost control and high rate of production which is currently not being met by the current state of the art material systems, like Carbon-Carbon. What is needed is a Thermal Protection System (TPS) for aero structures that can survive the Hypersonic environments of high heat in oxygenated environments. A means to do this is using Peregr ...

    STTR Phase I 2023 Department of DefenseDefense Logistics Agency
  5. Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids

    SBC: INTELLIGENT OPTICAL SYSTEMS, INC.            Topic: CBD20AT001

    Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...

    STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  6. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  7. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  8. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  9. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  10. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government